• Profile
Close

Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions

AIDS Oct 08, 2018

Liu Y, et al. – In this retrospective study, researchers investigated the predictive value of biomarker P16INK4a for progression risk of anal low-grade squamous intraepithelial lesions (LSILs). They performed surveillance high-resolution anoscopy and biopsy on 109 HIV-infected and 18 HIV-uninfected individuals with biopsy-confirmed anal LSIL at initial screening within 2 years of diagnosis. Performing P16 immunohistochemistry on index lesions, they identified biomarker P16 to be the strongest predictor for anal LSIL-to-high-grade squamous intraepithelial lesion progression, outperforming other risk factors. Hence, they recommend using P16 immunohistochemistry to help stratify patients at high vs low risk of progression to improve the overall effectiveness of surveillance.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay